This in‑depth guide explains why the 2025 deadlines—particularly DSCSA’s interoperable data exchange requirement—represent a watershed moment for the pharma supply chain.
Partnering for Resilience: How New Alliances Are Strengthening Pharma Supply Chains in 2025
Little wonder that 37% of life science executives now identify building “resilient and adaptable supply chains” as a top priority entering 2025. The key to this resilience? Increasingly, it’s strategic partnerships.
Pharma Supply Chain 2.0: Embracing Automation and Digitalization to Boost Agility in 2025
Pharma Supply Chain 2.0 refers to this next-generation supply chain – one that embraces process automation and end-to-end digitalization (beyond just AI hype) to boost agility, responsiveness, and efficiency.
Beyond the Cold Chain: Adapting Pharma Supply Chains for Next-Gen Therapies in 2025
Explore how pharma supply chains are adapting beyond traditional cold chain logistics to effectively deliver next-gen therapies like personalized medicines and biologics in 2025.
Automation & Robotics for an Autonomous Supply Chain
Discover how automation and robotics are transforming supply chains into autonomous operations, boosting efficiency, resilience, and agility across industries.
